These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27230994)
21. High-dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Massardo L; Jacobelli S; Leissner M; González M; Villarroel L; Rivero S Lupus; 1992 Dec; 1(6):401-5. PubMed ID: 1304409 [TBL] [Abstract][Full Text] [Related]
22. Osteonecrosis of the hip in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome. Lee J; Kwok SK; Jung SM; Min HK; Nam HC; Seo JH; Ju J; Park KS; Park SH; Kim HY Lupus; 2014; 23(1):39-45. PubMed ID: 24335586 [TBL] [Abstract][Full Text] [Related]
23. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study. Faezi ST; Hoseinian AS; Paragomi P; Akbarian M; Esfahanian F; Gharibdoost F; Akhlaghi M; Nadji A; Jamshidi AR; Shahram F; Nejadhosseinian M; Davatchi F Mod Rheumatol; 2015 Jul; 25(4):590-4. PubMed ID: 25528860 [TBL] [Abstract][Full Text] [Related]
24. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Nagasawa K; Tada Y; Koarada S; Horiuchi T; Tsukamoto H; Murai K; Ueda A; Yoshizawa S; Ohta A Lupus; 2005; 14(5):385-90. PubMed ID: 15934439 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with osteonecrosis in Thai lupus patients: a case control study. Uea-areewongsa P; Chaiamnuay S; Narongroeknawin P; Asavatanabodee P J Clin Rheumatol; 2009 Oct; 15(7):345-9. PubMed ID: 20009970 [TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics and risk factors in 118 patients with systemic lupus erythematosus and osteonecrosis]. Li NN; Chen YJ; Leng XM; Zhang W; Tian XP; Zhao Y; Zeng XF Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):744-750. PubMed ID: 34304451 [No Abstract] [Full Text] [Related]
27. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup? Catoggio LJ; Soriano ER; Imamura PM; Wojdyla D; Jacobelli S; Massardo L; Chacón Díaz R; Guibert-Toledano M; Alvarellos A; Saurit V; Manni JA; Pascual-Ramos V; Silva de Sauza AW; Bonfa E; Tavares Brenol JC; Ramirez LA; Barile-Fabris LA; De La Torre IG; Alarcón GS; Pons-Estel BA; Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653 [TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of multifocal osteonecrosis in Korean patients with rheumatic disease. Jeong HJ; Kim D; Cho SK; Kim Y; Bae SC; Sung YK Int J Rheum Dis; 2018 Jun; 21(6):1301-1308. PubMed ID: 28328178 [TBL] [Abstract][Full Text] [Related]
29. [Ischemic necrosis of femoral condyles in systemic lupus erythematosus]. Caldore M; Ravelli A; Viola S; Beluffi G; Martini A Minerva Pediatr; 1989 Jan; 41(1):41-4. PubMed ID: 2733640 [TBL] [Abstract][Full Text] [Related]
30. Clinical features and associated factors of abdominal pain in systemic lupus erythematosus. Yuan S; Lian F; Chen D; Li H; Qiu Q; Zhan Z; Ye Y; Xu H; Liang L; Yang X J Rheumatol; 2013 Dec; 40(12):2015-22. PubMed ID: 24187097 [TBL] [Abstract][Full Text] [Related]
31. Anti-RNP Antibody: A Potential Novel Predictor for Osteonecrosis in Systemic Lupus Erythematosus. Xiong J; Wang G; Xu T; Liu R; Yu S; Wang Y; Wu R Front Med (Lausanne); 2022; 9():847875. PubMed ID: 35479947 [TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study. Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177 [TBL] [Abstract][Full Text] [Related]
33. Development of new osteonecrosis in systemic lupus erythematosus patients in association with long-term corticosteroid therapy after disease recurrence. Nakamura J; Ohtori S; Sakamoto M; Chuma A; Abe I; Shimizu K Clin Exp Rheumatol; 2010; 28(1):13-8. PubMed ID: 20346232 [TBL] [Abstract][Full Text] [Related]
34. Additive risk factors resulting in severe osteonecrosis in systemic lupus erythematosus. Duran-Barragan S; Sandoval-Garcia L; Navarrete-Lorenzon M Arthritis Rheum; 2010 Nov; 62(11):3276. PubMed ID: 20669286 [No Abstract] [Full Text] [Related]
35. Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus. Al Saleh J; El Sayed M; Salah N; Harb D; Khan N; Mohammed N Egypt J Immunol; 2010; 17(1):29-40. PubMed ID: 22053607 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study. Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666 [TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine in patients with systemic lupus erythematosus with end-stage renal disease. Bethel M; Yang FM; Li S; Nahman NS; Oliver AM; Machua W; Carbone LD J Investig Med; 2016 Apr; 64(4):908-10. PubMed ID: 26911274 [TBL] [Abstract][Full Text] [Related]
40. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Mont MA; Fairbank AC; Petri M; Hungerford DS Clin Orthop Relat Res; 1997 Jan; (334):91-7. PubMed ID: 9005900 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]